<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Samsrita Labs Ltd (formerly Dr Habeebullah Life Sciences Limited) has informed BSE and Metropolitan Stock Exchange that as on 31 March 2025, the company does not fall under the 'Large Corporate (LC)' category as per the SEBI Circular dated 26 November 2018. Accordingly, the mandatory annual disclosures required from Large Corporates regarding debt security fundraising are not applicable to the company. The communication was signed by K.N.V. Narendra Kumar, Whole-time Director & CFO, on 10 April 2025.
This is a routine compliance filing with no material impact on shareholders or the stock price. It simply confirms that the company does not meet the size thresholds for enhanced disclosure obligations meant for large entities, suggesting its borrowings and scale are below the Large Corporate benchmark.